Dose wisely! How lipid-lowering undertreatment can lead to overtreatment

L. Masana (Luis) and Lennep, J.R.V. (Jeanine Roeters van)

2016-12-01

Atherosclerosis , Volume 255 p. 126- 127

Additional Metadata
Keywords	LDL cholesterol, LDL targets, Lipid lowering therapy, PCSK9 inhibitors, Treatment adherence, Undertreatment
Persistent URL	doi.org/10.1016/j.atherosclerosis.2016.10.014, hdl.handle.net/1765/94574
Journal	Atherosclerosis
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Masana, L., & Lennep, J.R.V. (Jeanine Roeters van). (2016). Dose wisely! How lipid-lowering undertreatment can lead to overtreatment. Atherosclerosis, 255, 126–127. doi:10.1016/j.atherosclerosis.2016.10.014

Publication